Muhammad Haneef Ghifari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Muhammad Haneef Ghifari has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Firyal Khansa
Medical Research Unit, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia
2 shared publications Muhammad B. Daffa
Medical Research Unit, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia
2 shared publications- Muhammad Iqhrammullah
Postgraduate Program of Public Health, Universitas Muhammadiyah Aceh, Banda Aceh, Indonesia
2 shared publications Amanda Yufika
Department of Family Medicine, Faculty of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia
1 shared publication- Amanda Yufika
Department of Family Medicine, Faculty of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia; Physical Medicine and Rehabilitation Residency Program, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia
1 shared publication Chairul Ichwan
Department of Cardiology and Vascular Medicine, Dr. Zainoel Abidin Hospital, Banda Aceh, Indonesia
1 shared publication
Latest Publications
- Open Access
- 21 April 2025
- Published by MDPI AG in Kidney and Dialysis
- Vol. 5 (2) , 16
Predictive Values of Handgrip Strength for Protein-Energy Wasting Among Patients Undergoing Maintenance Hemodialysis: A Systematic Review and Meta-Analysis
Protein-energy wasting (PEW) increases the morbidity and mortality in maintenance hemodialysis (MHD) patients. The existing screening tools (e.g., Malnutrition-Inflammation Score (MIS)) are time-consuming and require expertise. Consequently, assessing a more practical and reliable tool such as handgrip strength (HGS) is important, as it strongly correlates with the PEW status in patients undergoing MHD, in whom increased protein and fat breakdown leads to muscle strength and function loss. A systematic search of five databases identified studies assessing HGS’s predictive value for PEW in patients undergoing MHD, using MIS as the reference. The quality of the studies was evaluated with the updated QUADAS tool. A diagnostic meta-analysis was carried out to estimate the pooled sensitivity, specificity, sROC, and sAUC using a two-level mixed-effects model. From 350 records, five studies were obtained which were included for analysis. The pooled sensitivity and specificity of the HGS among male patients were 68% (95%CI: 63–73%) and 66% (95%CI: 53–77%), respectively. Among female patients, the pooled sensitivity and specificity were 73% (95%CI: 62–82%) and 65% (95%CI: 48–79%), respectively. The positive likelihood ratio and negative likelihood ratio for male patients were 2.0 (95%CI: 1.4 to 2.9) and 0.48 (95%CI: 0.38 to 0.60), respectively. Meanwhile, among female patients, the positive likelihood ratio and negative likelihood ratio were 2.1 (95%CI: 1.4–3.1) and 0.41 (95%CI: 0.29–0.59), respectively. The sAUC for males and females was estimated to be 0.69 (95%CI: 0.65 to 0.73) and 0.75 (95%CI: 0.71–0.79). In summary, the sensitivity and specificity of the HGS were modest for all sexes, with females being more sensitive. HGS may be useful for triaging during daily screening and guiding further examination, but it requires supporting measurements to be employed as a diagnostic tool. PROSPERO: CRD42024595677 as of 1 October 2024.
- 21 April 2025
- Published by MDPI AG in Kidney and Dialysis
- Vol. 5 (2) , 16
Open AccessPredictive Values of Handgrip Strength for Protein-Energy Wasting Among Patients Undergoing Maintenance Hemodialysis: A Systematic Review and Meta-Analysis
Protein-energy wasting (PEW) increases the morbidity and mortality in maintenance hemodialysis (MHD) patients. The existing screening tools (e.g., Malnutrition-Inflammation Score (MIS)) are time-consuming and require expertise. Consequently, assessing a more practical and reliable tool such as handgrip strength (HGS) is important, as it strongly correlates with the PEW status in patients undergoing MHD, in whom increased protein and fat breakdown leads to muscle strength and function loss. A systematic search of five databases identified studies assessing HGS’s predictive value for PEW in patients undergoing MHD, using MIS as the reference. The quality of the studies was evaluated with the updated QUADAS tool. A diagnostic meta-analysis was carried out to estimate the pooled sensitivity, specificity, sROC, and sAUC using a two-level mixed-effects model. From 350 records, five studies were obtained which were included for analysis. The pooled sensitivity and specificity of the HGS among male patients were 68% (95%CI: 63–73%) and 66% (95%CI: 53–77%), respectively. Among female patients, the pooled sensitivity and specificity were 73% (95%CI: 62–82%) and 65% (95%CI: 48–79%), respectively. The positive likelihood ratio and negative likelihood ratio for male patients were 2.0 (95%CI: 1.4 to 2.9) and 0.48 (95%CI: 0.38 to 0.60), respectively. Meanwhile, among female patients, the positive likelihood ratio and negative likelihood ratio were 2.1 (95%CI: 1.4–3.1) and 0.41 (95%CI: 0.29–0.59), respectively. The sAUC for males and females was estimated to be 0.69 (95%CI: 0.65 to 0.73) and 0.75 (95%CI: 0.71–0.79). In summary, the sensitivity and specificity of the HGS were modest for all sexes, with females being more sensitive. HGS may be useful for triaging during daily screening and guiding further examination, but it requires supporting measurements to be employed as a diagnostic tool. PROSPERO: CRD42024595677 as of 1 October 2024.
- Open Access
- 31 December 2024
- Published by Narra Sains Indonesia in Narra X
- Vol. 2 (3) , e181
Global prevalence of natural disaster-induced acute respiratory infections: A systematic review and meta-analysis of 290,380 participants
Acute respiratory infections (ARI) can be caused by the occurrence of natural disasters such as earthquakes, volcanic eruptions, landslides, tsunamis, floods, and droughts. The aim of this study was to determine the global prevalence of acute respiratory infections during post-natural disasters across countries. A systematic review and meta-analysis were conducted in accordance with the PRISMA guidelines. Studies reporting acute respiratory infections prevalence in natural disaster-impacted areas were identified and screened from PubMed, Scopus, Crosreff, Scilit, and medRxiv as of March 16th, 2024. The meta-analysis was conducted using the Freeman-Tukey double arcsine transformation with a random-effects model. A total of 15 out of 2,052 studies, covering 290,380 subjects, were included in the meta-analysis. The pooled estimate of acute respiratory infection prevalence following natural disasters across multiple countries was 43.0% (95% confidence interval (CI): 31–55%; p-Het<0.01; I²=99.97%). No statistical significance was observed between subgroups, including population density (p=0.281), country income (p=0.583), and types of disasters (p=0.468), suggesting the indiscriminate nature of disaster-induced acute respiratory infections. The highest prevalence was observed in studies from 2015–2019, with a prevalence of 52% (95%CI: 32.7–72.2%; p-Het<0.001; I²=99.97%). In conclusion, the global prevalence of disaster-induced ARI is considered high, reaching 43%, highlighting the need for countermeasures to address these diseases during disasters.
- 31 December 2024
- Published by Narra Sains Indonesia in Narra X
- Vol. 2 (3) , e181
Open AccessGlobal prevalence of natural disaster-induced acute respiratory infections: A systematic review and meta-analysis of 290,380 participants
Acute respiratory infections (ARI) can be caused by the occurrence of natural disasters such as earthquakes, volcanic eruptions, landslides, tsunamis, floods, and droughts. The aim of this study was to determine the global prevalence of acute respiratory infections during post-natural disasters across countries. A systematic review and meta-analysis were conducted in accordance with the PRISMA guidelines. Studies reporting acute respiratory infections prevalence in natural disaster-impacted areas were identified and screened from PubMed, Scopus, Crosreff, Scilit, and medRxiv as of March 16th, 2024. The meta-analysis was conducted using the Freeman-Tukey double arcsine transformation with a random-effects model. A total of 15 out of 2,052 studies, covering 290,380 subjects, were included in the meta-analysis. The pooled estimate of acute respiratory infection prevalence following natural disasters across multiple countries was 43.0% (95% confidence interval (CI): 31–55%; p-Het<0.01; I²=99.97%). No statistical significance was observed between subgroups, including population density (p=0.281), country income (p=0.583), and types of disasters (p=0.468), suggesting the indiscriminate nature of disaster-induced acute respiratory infections. The highest prevalence was observed in studies from 2015–2019, with a prevalence of 52% (95%CI: 32.7–72.2%; p-Het<0.001; I²=99.97%). In conclusion, the global prevalence of disaster-induced ARI is considered high, reaching 43%, highlighting the need for countermeasures to address these diseases during disasters.
- Open Access
- 25 September 2024
- Published by Narra Sains Indonesia in Narra X
- Vol. 2 (2) , e164
Hydroxyurea therapy for children with sickle cell anemia: A systematic review and meta-analysis
Sickle cell anemia (SCA) is a major global health issue, particularly among pediatric population, influenced by factors such as malaria susceptibility and genetic distribution. On the other hand, hydroxyurea therapy has been a well-established and accepted treatment for SCA, with over 25 years of clinical experience. It has been proven to be safe and effective in preventing vaso-occlusive events and chronic organ damage. The aim of this study was to assess the efficacy of hydroxyurea in alleviating pediatric SCA. This study was comprised of a systematic literature search and meta-analysis in accordance with the PRISMA and the Cochrane Handbook guidelines. A systematic search was performed on PubMed, Cochrane, and ScienceDirect databases for relevant literature published as of January 2024. Placebo-controlled clinical trials reporting the efficacy of hydroxyurea in managing SCA among pediatric patients were included in the systematic review. The eligible studies were further assessed for its reporting quality using Risk of Bias 2.0. Pooled analysis was carried out using a random effect model, where the effect size was calculated based on the mean difference (MD) and 95% confidence interval (95%CI). Three randomized clinical trials comprised of 423 participants were included in the studies. Among patients receiving hydroxyurea, significant improvement was observed in fetal hemoglobin (HbF) with MD of 9.45% (95%CI: 2.15–16.75), but not in mean corpuscular volume (MCV) (MD=8.77 fL (95%CI: -28.85–46.39). Hydroxyurea also significantly reduced white blood cell (WBC) (MD=-4.21 cells/mm3; 95%CI: -5.68–-2.93), absolute neutrophil count (ANC) (MD=-1.43 cells/mm3; 95%CI: -2.11–-0.74), absolute reticulocyte count (ARC) (MD=-141.85 cells/mm3; 95%CI; -172.77–-110.94), and platelet count (MD=-74.92 cells/mm3; 95%CI: -117.05–-32.78). In conclusion, hydroxyurea is efficacious in treating pediatric SCA, as observed in the HbF, WBC, ANC, ARC, and platelet count.
- 25 September 2024
- Published by Narra Sains Indonesia in Narra X
- Vol. 2 (2) , e164
Open AccessHydroxyurea therapy for children with sickle cell anemia: A systematic review and meta-analysis
Sickle cell anemia (SCA) is a major global health issue, particularly among pediatric population, influenced by factors such as malaria susceptibility and genetic distribution. On the other hand, hydroxyurea therapy has been a well-established and accepted treatment for SCA, with over 25 years of clinical experience. It has been proven to be safe and effective in preventing vaso-occlusive events and chronic organ damage. The aim of this study was to assess the efficacy of hydroxyurea in alleviating pediatric SCA. This study was comprised of a systematic literature search and meta-analysis in accordance with the PRISMA and the Cochrane Handbook guidelines. A systematic search was performed on PubMed, Cochrane, and ScienceDirect databases for relevant literature published as of January 2024. Placebo-controlled clinical trials reporting the efficacy of hydroxyurea in managing SCA among pediatric patients were included in the systematic review. The eligible studies were further assessed for its reporting quality using Risk of Bias 2.0. Pooled analysis was carried out using a random effect model, where the effect size was calculated based on the mean difference (MD) and 95% confidence interval (95%CI). Three randomized clinical trials comprised of 423 participants were included in the studies. Among patients receiving hydroxyurea, significant improvement was observed in fetal hemoglobin (HbF) with MD of 9.45% (95%CI: 2.15–16.75), but not in mean corpuscular volume (MCV) (MD=8.77 fL (95%CI: -28.85–46.39). Hydroxyurea also significantly reduced white blood cell (WBC) (MD=-4.21 cells/mm3; 95%CI: -5.68–-2.93), absolute neutrophil count (ANC) (MD=-1.43 cells/mm3; 95%CI: -2.11–-0.74), absolute reticulocyte count (ARC) (MD=-141.85 cells/mm3; 95%CI; -172.77–-110.94), and platelet count (MD=-74.92 cells/mm3; 95%CI: -117.05–-32.78). In conclusion, hydroxyurea is efficacious in treating pediatric SCA, as observed in the HbF, WBC, ANC, ARC, and platelet count.
- Open Access
- 1 September 2024
- Published by Wolters Kluwer Health in Annals of Pediatric Cardiology
- Vol. 17 (5) , 313-319
Prevalence of Vitamin D deficiency among individuals with Fontan palliation: A systematic review and meta-analysis
Background: Children with one functional ventricle might receive the Fontan procedure as palliative management to prolong their lives. However, the heart remains functionally univentricular, which may result in disrupted absorption of nutrients, including Vitamin D. Individuals with Fontan circulation have limited physical activity and sun exposure, which might further contribute to Vitamin D deficiency. Objective: This study aimed to estimate the prevalence of Vitamin D deficiency among individuals with Fontan circulation and analyze probable contributing factors to it through meta-regression analysis. Methods: A predetermined search strategy was applied on PubMed, Scopus, Scilit, Web of Science, Europe PMC, and Google Scholar to identify relevant literature as of July 2024. In general, studies reporting the prevalence or incidence of Vitamin D deficiency (I 2 = 84.38%; p-Het P = 0.003) was the main contributor to the heterogeneity. Conclusion: Vitamin D deficiency is highly prevalent among individuals with Fontan palliation, highlighting the need for active monitoring and investigation into the benefits of Vitamin D supplementation. PROSPERO registration: CRD42024574724.
- 1 September 2024
- Published by Wolters Kluwer Health in Annals of Pediatric Cardiology
- Vol. 17 (5) , 313-319
Open AccessPrevalence of Vitamin D deficiency among individuals with Fontan palliation: A systematic review and meta-analysis
Background: Children with one functional ventricle might receive the Fontan procedure as palliative management to prolong their lives. However, the heart remains functionally univentricular, which may result in disrupted absorption of nutrients, including Vitamin D. Individuals with Fontan circulation have limited physical activity and sun exposure, which might further contribute to Vitamin D deficiency. Objective: This study aimed to estimate the prevalence of Vitamin D deficiency among individuals with Fontan circulation and analyze probable contributing factors to it through meta-regression analysis. Methods: A predetermined search strategy was applied on PubMed, Scopus, Scilit, Web of Science, Europe PMC, and Google Scholar to identify relevant literature as of July 2024. In general, studies reporting the prevalence or incidence of Vitamin D deficiency (I 2 = 84.38%; p-Het P = 0.003) was the main contributor to the heterogeneity. Conclusion: Vitamin D deficiency is highly prevalent among individuals with Fontan palliation, highlighting the need for active monitoring and investigation into the benefits of Vitamin D supplementation. PROSPERO registration: CRD42024574724.